Bicara Therapeutics Inc.

BCAX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Jan 13, 2025 8-K
10-Q Nov 12, 2024 10-Q
8-K Nov 12, 2024 8-K
SC 13G Sep 26, 2024 SC 13G
SC 13G Sep 26, 2024 SC 13G
SC 13D Sep 23, 2024 SC 13D
4 Sep 18, 2024
SC 13D Sep 18, 2024 SCHEDULE TO REPORT BENEFICIAL OWNERSHIP OF 5% OR MORE
4 Sep 18, 2024
SC 13G Sep 18, 2024
4 Sep 18, 2024 4
4 Sep 18, 2024 4
4 Sep 17, 2024
4 Sep 16, 2024
4 Sep 16, 2024 4
4 Sep 16, 2024 4
4 Sep 16, 2024 4
4 Sep 16, 2024 4
4 Sep 16, 2024 4
4 Sep 16, 2024 4
8-K Sep 16, 2024 8-K
SEC STAFF LETTER Sep 13, 2024
S-8 Sep 13, 2024 S-8
424B4 Sep 13, 2024 424B4
EFFECT Sep 12, 2024
← Newer Page 9 of 11 · 263 filings Older →